Folic Acid Prescribing and Reproductive Counseling Practices of Child Neurologists for Women With Epilepsy

IF 3.2 3区医学 Q2 CLINICAL NEUROLOGY

Pediatric neurology Pub Date : 2025-01-24 DOI:10.1016/j.pediatrneurol.2025.01.015

Mariah Ozkir MD, Derryl Miller MD

{"title":"Folic Acid Prescribing and Reproductive Counseling Practices of Child Neurologists for Women With Epilepsy","authors":"Mariah Ozkir MD, Derryl Miller MD","doi":"10.1016/j.pediatrneurol.2025.01.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Women with epilepsy (WWE) experience stigma related to reproductive health. Pediatric neurologists are often uncomfortable providing age-appropriate reproductive health counseling (RHC) and prescribing folic acid (FA). We studied RHC and FA prescribing practices for child neurologists and provide a literature review for FA dosing maximizing benefit for WWE and their children.</div></div><div><h3>Methods</h3><div>We performed a retrospective cross-sectional study of RHC and FA prescribing by child neurologists at our center for 227 consecutive WWE from January to June 2022. We studied patient age, teratogenic risk of antiseizure medications (ASMs), number of ASMs, presence/absence of intellectual disability (ID), and physician board certification. ASM teratogenic risk was determined utilizing the North American Antiepileptic Drug Pregnancy Registry (NAADPR) database with ≥2.5% threshold of major malformation for high risk, <2.5% for low risk, and no NAADPR data for unknown risk.</div></div><div><h3>Results</h3><div>Pediatric neurologists inconsistently prescribe FA (11%) and document RHC (10%). WWE on valproic acid receive FA more often (31% vs 9.6%, <em>P</em> = 0.004, χ<sup>2</sup> = 8.28) but similar RHC to WWE on other ASMs (<em>P</em> = 0.080, χ<sup>2</sup> = 3.06). Epileptologists do not prescribe FA more than general neurologists (<em>P</em> = 0.65, χ<sup>2</sup> = 0.19), and general neurologists document RHC more often (18% vs 4%, <em>P</em> = 0.00047, χ<sup>2</sup> = 4.21). WWE aged 16-18 years receive RHC more than WWE aged 12-15 years (12.7% vs 10.5%, <em>P</em> = 0.025, χ<sup>2</sup> = 4.96) with no difference in FA prescriptions (<em>P</em> = 0.60, χ<sup>2</sup> = 0.27). Patients with ID receive FA less often (6% vs 15%, <em>P</em> = 0.035, χ<sup>2</sup> = 4.44) with no difference in RHC (<em>P</em> = 0.29, χ<sup>2</sup> = 1.09).</div></div><div><h3>Conclusions</h3><div>We quantify a significant gap in care for WWE to facilitate quality improvement initiatives. Preconceptional FA 1 mg orally daily seems appropriate for WWE with present knowledge.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"165 ","pages":"Pages 52-55"},"PeriodicalIF":3.2000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric neurology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887899425000232","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Women with epilepsy (WWE) experience stigma related to reproductive health. Pediatric neurologists are often uncomfortable providing age-appropriate reproductive health counseling (RHC) and prescribing folic acid (FA). We studied RHC and FA prescribing practices for child neurologists and provide a literature review for FA dosing maximizing benefit for WWE and their children.

Methods

We performed a retrospective cross-sectional study of RHC and FA prescribing by child neurologists at our center for 227 consecutive WWE from January to June 2022. We studied patient age, teratogenic risk of antiseizure medications (ASMs), number of ASMs, presence/absence of intellectual disability (ID), and physician board certification. ASM teratogenic risk was determined utilizing the North American Antiepileptic Drug Pregnancy Registry (NAADPR) database with ≥2.5% threshold of major malformation for high risk, <2.5% for low risk, and no NAADPR data for unknown risk.

Results

Pediatric neurologists inconsistently prescribe FA (11%) and document RHC (10%). WWE on valproic acid receive FA more often (31% vs 9.6%, P = 0.004, χ² = 8.28) but similar RHC to WWE on other ASMs (P = 0.080, χ² = 3.06). Epileptologists do not prescribe FA more than general neurologists (P = 0.65, χ² = 0.19), and general neurologists document RHC more often (18% vs 4%, P = 0.00047, χ² = 4.21). WWE aged 16-18 years receive RHC more than WWE aged 12-15 years (12.7% vs 10.5%, P = 0.025, χ² = 4.96) with no difference in FA prescriptions (P = 0.60, χ² = 0.27). Patients with ID receive FA less often (6% vs 15%, P = 0.035, χ² = 4.44) with no difference in RHC (P = 0.29, χ² = 1.09).

Conclusions

We quantify a significant gap in care for WWE to facilitate quality improvement initiatives. Preconceptional FA 1 mg orally daily seems appropriate for WWE with present knowledge.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric neurology 医学-临床神经学

CiteScore

4.80

自引率

2.60%

发文量

176

审稿时长

78 days

期刊介绍： Pediatric Neurology publishes timely peer-reviewed clinical and research articles covering all aspects of the developing nervous system. Pediatric Neurology features up-to-the-minute publication of the latest advances in the diagnosis, management, and treatment of pediatric neurologic disorders. The journal''s editor, E. Steve Roach, in conjunction with the team of Associate Editors, heads an internationally recognized editorial board, ensuring the most authoritative and extensive coverage of the field. Among the topics covered are: epilepsy, mitochondrial diseases, congenital malformations, chromosomopathies, peripheral neuropathies, perinatal and childhood stroke, cerebral palsy, as well as other diseases affecting the developing nervous system.